This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Biotech Stocks Under $10 Making Big Moves

BioCryst Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

BioCryst Pharmaceuticals ( BCRX) is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock closed up 3.4% to $7.24 in Thursday's trading session.

Thursday's Range: $6.96-$7.25
52-Week Range: $1.08-$7.41
Thursday's Volume: 1.39 million
Three-Month Average Volume: 2.51 million

>>5 Rocket Stocks to Buy for September Gains

From a technical perspective, BCRX jumped higher here with lighter-than-average volume. This stock has been trending sideways and consolidating for the last month and change, with shares moving between $6.07 on the downside and $7.41 on the upside. Shares of BCRX are now quickly moving within range of triggering a breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if BCRX manages to take out Thursday's high at $7.25 and its 52-week high at $7.41 with high volume.

Traders should now look for long-biased trades in BCRX as long as it's trending above some near-term support at $6.50 or at $6.07, and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.51 million shares. If that breakout hits soon, then BCRX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $9 to $10.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CXM $0.65 -1.52%
BCRX $15.26 -2.93%
SNTA $2.11 -4.52%
AAPL $122.99 -0.32%
FB $96.99 1.78%

Markets

Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.57 +15.32 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs